On December 27, 2023, Chief Judge Catherine Eagles of the U.S. District Court for the Middle District of North Carolina granted a motion for preliminary injunction by Natera Inc. enjoining NeoGenomics Laboratories Inc. from...more
1/19/2024
/ Abbreviated New Drug Application (ANDA) ,
Genetic Materials ,
Genetic Testing ,
Hatch-Waxman ,
Irreparable Harm ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Public Interest ,
Treatment Method Patents